Impact on Mortality of Cardiovascular Treatments Interruption in a Medical Intensive Care Unit
试验速览
- 阶段
- 不适用
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- ICU Mortality
研究概览
简要总结
Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified. The question of the study is to investigate wether such treatment interruption might be responsible for prognosis modifications.
详细描述
Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted and/or modified.
Few studies have investigated the outcome impact of medications interruption and/or modifications following hospital admission. We did consider that it might be interesting to study whether treatment continuation, interruption, and/or re-introduction following ICU admission may modify patients' outcome either in the ICU or following hospital discharge (at 3,6 and 12 months).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 15 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients with cardiovascular treatment prior to ICU admission
排除标准
- •Data unavailability
- •Consent withdrawal following information
结局指标
主要结局
ICU Mortality
时间窗: 2 months following ICU Discharge
Patients mortality will be assessed at the end of the ICU stay (two months)
次要结局
- Mortality at Month 3 following discharge(3-months following discharge)
- Hospital mortality(2 months following Hospital Discharge)
- Mortality at Month 6 following discharge(6-months following discharge)
- Mortality at Month 12 (1-year) following discharge(12-months following discharge)